UPDATE: H.C. Wainwright Downgrades EyePoint Pharmaceuticals, Inc. (EYPT) to Neutral
Tweet Send to a Friend
(Updated - November 11, 2019 7:42 AM EST)
(updated comment)H.C. Wainwright analyst Raghuram Selvaraju downgraded EyePoint Pharmaceuticals, Inc. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated comment)H.C. Wainwright analyst Raghuram Selvaraju downgraded EyePoint Pharmaceuticals, Inc. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
